Pharmacy Practice
Affordable Medicines
Compounding
Drug Approvals
Geriatrics
Hospital/Health System
In-Pharmacy Vaccines
Law
Medication Management
News & Trends
OTC
Specialty Pharmacy
Technology
Disease State
Allergy
Autoimmune
Breast Cancer
Cardiovascular
Cold & Flu
Dermatology
Diabetes
Gastroenterology
Hematology
HIV/AIDS
Infectious Disease
Mental Health
Neurology
Oncology
Ophthalmology
Orthopedics
Pain Management
Pediatrics
Respiratory
Urology/Nephrology
Women’s Health
Videos
Patient Teaching Aid
Publications
Featured Issue
Featured Supplements
Conference Coverage
Continuing Education
Subscribe
Jobs
ONCOLOGY
November 20, 2019
Review Updates USPSTF Information on Breast Cancer Primary Prevention
November 15, 2019
Managing Common Toxicities Associated With Immune Checkpoint Inhibitors
October 22, 2019
Pharmacogenomics Guide Oncology Treatments
October 17, 2019
Why Not All Prostate-Cancer Patients Should Get Hormone Therapy After Surgery
September 17, 2019
Abbott RealTime IDH1
September 12, 2019
Trial Targets Options for Urothelial Carcinoma
August 22, 2019
Metabolic Changes May Predict Anthracycline Cardiotoxicity
August 22, 2019
Ice Chips Prevent Hyperalgesia With Oxaliplatin
August 22, 2019
Enzalutamide and ADT Reduce Prostate Cancer Progression Risk
August 19, 2019
Basal Cell Carcinoma: A Pharmacist’s Guide
August 16, 2019
PSA Test
July 17, 2019
ADT for Prostate Cancer Increases Risk for Alzheimer’s, Other Dementia
July 3, 2019
Statins Appear to Reduce CVD Events in Cancer Patients Receiving Radiation
Load More
X
November 2019
In This Issue
Digital Magazine
Archives
Subscription
Related CE
$6.97 Per CE Exam or $59 for 12 Lessons
Immunoglobulin G: A Primary Strategy in Secondary Immunodeficiency
Examining Real World Evidence in the Management of Breast Cancer: Pharmacist Implications
×
Full Image